Benzbromarone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12319 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 32 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypouricemia, renal | KG + DL |
| 2 | Lesch-Nyhan syndrome | KG + DL |
| 3 | hypoxanthine guanine phosphoribosyltransferase partial deficiency | KG + DL |
| 4 | homozygous familial hypercholesterolemia | KG + DL |
| 5 | glycogen storage disease | KG + DL |
| 6 | glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form | KG + DL |
| 7 | glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form | KG + DL |
| 8 | tricarboxylic acid cycle disorder | KG + DL |
| 9 | hepatoportal sclerosis | KG + DL |
| 10 | primitive portal vein thrombosis | KG + DL |
| 11 | hepatopulmonary syndrome | KG + DL |
| 12 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 13 | idiopathic copper-associated cirrhosis | KG + DL |
| 14 | hepatic porphyria | KG + DL |
| 15 | adult polyglucosan body disease | KG + DL |
| 16 | disease of transporter activity | KG + DL |
| 17 | glycogen storage disease due to hepatic glycogen synthase deficiency | KG + DL |
| 18 | pyruvate metabolism disorder | KG + DL |
| 19 | hereditary renal hypouricemia | KG + DL |
| 20 | inborn disorder of fatty acid oxidation and ketone body metabolism | KG + DL |
| 21 | familial hyperlipidemia | KG + DL |
| 22 | glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form | KG + DL |
| 23 | glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form | KG + DL |
| 24 | glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form | KG + DL |
| 25 | glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form | KG + DL |
| 26 | glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form | KG + DL |
| 27 | inborn disorder of bilirubin metabolism | KG + DL |
| 28 | benign recurrent intrahepatic cholestasis | KG + DL |
| 29 | hereditary North American Indian childhood cirrhosis | KG + DL |
| 30 | bilirubin metabolism disease | KG + DL |
| 31 | familial intrahepatic cholestasis | KG + DL |
| 32 | porphyria due to ALA dehydratase deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.